SVEP1 and intrahepatic cholangiocarcinoma: Given that decreased SVEP1 expression promotes EMT phenotype switching of ICC, cell migration, and invasion in vitro and in vivo, we speculate that these effects stem from reduced SVEP1 binding to integrin α9β1.